Further clinical studies should explore whether the inflammatory cytokines we identified in our study (IL-6, IL-8, IL-1β, TNF, IL-10, and IL-12p70) could potentially serve as biomarkers for disease progression and response to therapy in HAM/TSP patients. This evidence concerns the gene IL6 and tropical spastic paraparesis.